We are live on
!
Find out more
TA
Townsend & Associates Portfolio holdings
AUM
$1.17B
1-Year Est. Return
20.72%
This Fund
S&P 500
This Quarter
Est. Return
+2.23%
1 Year Est. Return
+20.72%
3 Year Est. Return
+54.14%
5 Year Est. Return
+61.84%
10 Year Est. Return
–
AUM
$389M
AUM Growth
+$139M
(+56%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
32.88%
Top 10 Holdings %
Top 10 Hldgs %
36.15%
Holding
124
New
8
Increased
68
Reduced
30
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDV
iShares Core High Dividend ETF
HDV
|
+$10.6M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$10.2M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$10.2M |
| 4 |
iShares Core 1-5 Year USD Bond ETF
ISTB
|
+$8.8M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$6.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$261K |
| 2 |
BCE
BCE
|
+$216K |
| 3 |
Public Storage
PSA
|
+$180K |
| 4 |
PVH
PVH
|
+$175K |
| 5 |
CVS Health
CVS
|
+$155K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 14.76% |
| 2 | Consumer Discretionary | 10.19% |
| 3 | Financials | 9.91% |
| 4 | Healthcare | 5.23% |
| 5 | Consumer Staples | 5.14% |
Similar funds
TFA
JAG
BBCM
FG
OA
MTC
PWAM
OWSCM
Townsend & Associates's Q2 2023 Portfolio in Review
As of Q2 2023, Townsend & Associates held 124 positions worth $389M, up 56% from $249M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Townsend & Associates deployed $128M of net new capital in Q2 2023, opening 8 new positions and adding to 68 existing holdings. Its largest new stake was D.R. Horton: 16,033 shares worth $2.1M.
By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Merck, an estimated $261K trimmed.
- Townsend & Associates's largest Q2 2023 buy was D.R. Horton: 16,033 shares worth $2.1M.
- Townsend & Associates added most to iShares Core High Dividend ETF in Q2 2023, an estimated $10.6M increase.
- Townsend & Associates's biggest Q2 2023 reduction was Merck, cutting an estimated $261K.
- Townsend & Associates fully exited BCE in Q2 2023, selling an estimated $216K.
- Townsend & Associates's ten largest holdings make up 36% of its $389M portfolio in Q2 2023.
- Townsend & Associates opened 8 new positions and closed 1 in Q2 2023.
- Townsend & Associates's portfolio value rose 56% quarter-over-quarter to $389M.
Based on Townsend & Associates's 13F filing for Q2 2023, filed 31 Jul 2023.